Back to Search Start Over

Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

Authors :
Schulz, Alexander
Baader, Stephan L
Niwa-Kawakita, Michiko
Jung, Marie Juliane
Bauer, Reinhard
Garcia, Cynthia
Zoch, Ansgar
Schacke, Stephan
Hagel, Christian
Mautner, Victor-Felix
Hanemann, C Oliver
Dun, Xin-Peng
Parkinson, David B
Weis, Joachim
Schröder, J Michael
Gutmann, David H
Giovannini, Marco
Morrison, Helen
Source :
Nature Neuroscience; Apr2013, Vol. 16 Issue 4, p426-433, 8p
Publication Year :
2013

Abstract

The autosomal dominant disorder neurofibromatosis type 2 (NF2) is a hereditary tumor syndrome caused by inactivation of the NF2 tumor suppressor gene, encoding merlin. Apart from tumors affecting the peripheral and central nervous systems, most NF2 patients develop peripheral neuropathies. This peripheral nerve disease can occur in the absence of nerve-damaging tumors, suggesting an etiology that is independent of gross tumor burden. We discovered that merlin isoform 2 (merlin-iso2) has a specific function in maintaining axonal integrity and propose that reduced axonal NF2 gene dosage leads to NF2-associated polyneuropathy. We identified a merlin-iso2-dependent complex that promotes activation of the GTPase RhoA, enabling downstream Rho-associated kinase to promote neurofilament heavy chain phosphorylation. Merlin-iso2-deficient mice exhibited impaired locomotor capacities, delayed sensory reactions and electrophysiological signs of axonal neuropathy. Sciatic nerves from these mice and sural nerve biopsies from NF2 patients revealed reduced phosphorylation of the neurofilament H subunit, decreased interfilament spacings and irregularly shaped axons. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10976256
Volume :
16
Issue :
4
Database :
Complementary Index
Journal :
Nature Neuroscience
Publication Type :
Academic Journal
Accession number :
95677765
Full Text :
https://doi.org/10.1038/nn.3348